Health Care M&A: Before, During, and After COVID-19
Overview: This panel discussion will evaluate the impact of the COVID-19 pandemic on mergers, acquisitions, and other transactions in health care, with particular attention to distressed transactions and valuation issues.
- Travis Jackson, Partner, King & Spalding LLP
- Emily Schmidt, Manager, VMG Health
- Rowena Manlapaz, Principal Counsel - Health Affairs and Technology Law, University of California, Office of the General Counsel
- William Aseltyne, Senior Vice President Legal Services, General Counsel, Chief of Staff and Assistant Secretary
- Yale New Haven Health